Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice. | Nucleic Acids Res | 2026 | 41574437 | PubTator, text mining | PubMed |
Hereditary Risk Assessment of Cancer Using Clinical History in Patients Diagnosed with Breast or Ovarian Cancer Receiving Treatment at Tertiary Care Hospital in Western Rajasthan - A Cross-sectional Study. | Ann Afr Med | 2026 | 41568657 | PubTator, text mining | PubMed |
| SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genome. | NAR Genom Bioinform | 2026 | 41551927 | PubTator, text mining | PubMed |
| High-throughput mapping of 6,888 RAD51D variants identifies distinct biochemical functions needed for homologous recombination and olaparib response. | bioRxiv | 2026 | 41542474 | PubTator, text mining | PubMed |
| Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databases. | Breast Cancer Res | 2026 | 41530809 | PubTator, text mining | PubMed |
| Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications. | Arch Gynecol Obstet | 2026 | 41528496 | PubTator, text mining | PubMed |
| Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach. | Gynecol Oncol | 2026 | 41520566 | PubTator, text mining | PubMed |
| Prevalence of Germline Variants in Breast, Ovarian, and Prostate Cancer in Uruguay. | Clin Genet | 2026 | 41511858 | PubTator, text mining | PubMed |
| Germline Pathogenic Variant Prediction Model for Tumor-Only Sequencing Based on Japanese Clinicogenomic Database. | Clin Cancer Res | 2026 | 41403154 | PubTator, text mining | PubMed |
| Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands. | Breast | 2026 | 41274190 | PubTator, text mining | PubMed |
| Cryo-electron microscopic visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2. | Science | 2026 | 41196948 | PubTator, text mining | PubMed |
| Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. | Am J Obstet Gynecol | 2026 | 41183726 | PubTator, text mining | PubMed |
| Therapeutic effects of G90'-ES2 protein complex from regenerated Eisenia fetida on radiation-induced skin injury. | J Ethnopharmacol | 2026 | 40953774 | PubTator, text mining | PubMed |
| Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor/normal paired comprehensive genomic profiling test, in Japan. | J Hum Genet | 2026 | 40926019 | PubTator, text mining | PubMed |
| Investigating the effects of the ARG258HIS mutation on RAD51C in inherited Fanconi Anemia and cancer disease. | J Biomol Struct Dyn | 2026 | 39648652 | PubTator, text mining | PubMed |
| Serous tubal intraepithelial carcinoma-looking into the earliest events of ovarian cancer development. | Acad Oncol | 2025 | 41878142 | PubTator, text mining | PubMed |
| Integrative sWGS: A New Paradigm for HRD Detection in Ovarian Cancer. | Int J Mol Sci | 2025 | 41465396 | PubTator, text mining | PubMed |
| Updated genetic testing in individuals with unexplained adenomatous polyposis and the diagnostic yield. | Fam Cancer | 2025 | 41296145 | PubTator, text mining | PubMed |
| Somatic Mutation Profiling and Therapeutic Landscape of Breast Cancer in the MENA Region. | Cells | 2025 | 41294844 | PubTator, text mining | PubMed |
| BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). | Cancer Res Commun | 2025 | 41231232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=5